James Hakim
Impact in
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
- HIV/AIDS Research and Interventions
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 26
- HIV/AIDS Research and Interventions 5
- Tuberculosis Research and Epidemiology 3
- Antifungal resistance and susceptibility 1
-
- HIV-related health complications and treatments 4
- Co-authors
- Cissy M Kityo (7 shared papers)Innocent T. Gangaidzo (1 shared paper)Jens Mielke (1 shared paper)Robert S. Heyderman (1 shared paper)Peter R. Mason (1 shared paper)Valerie J. Robertson (1 shared paper)Andrew Ddungu Kambugu (2 shared papers)Paula Munderi (9 shared papers)
- Journals
- New England Journal of Medicine (5 papers)The Lancet HIV (4 papers)Clinical Infectious Diseases (4 papers)BMC Infectious Diseases (2 papers)PLoS Medicine (2 papers)
- Partner nations
- ZimbabweUnited KingdomUganda
In The Last Decade
James Hakim
37 papers receiving 2.3k citations
James Hakim's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 1.7k
- Virology 129
- Emergency Medicine 141
- Epidemiology 212
- Nephrology 65
Countries citing papers authored by James Hakim
This map shows the geographic impact of James Hakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hakim more than expected).
Fields of papers citing papers by James Hakim
This network shows the impact of papers produced by James Hakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hakim. The network helps show where James Hakim may publish in the future.
Co-authors
The 25 scholars most cited alongside James Hakim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis Hit paper breakdown → | 2011 | 451 |
| 2 | Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Hit paper breakdown → | 2021 | 372 |
| 3 | 2014 | 199 | |
| 4 | 2000 | 190 | |
| 5 | 2014 | 176 | |
| 6 | 2008 | 135 | |
| 7 | 2021 | 123 | |
| 8 | 2012 | 113 | |
| 9 | 2022 | 99 | |
| 10 | 2015 | 71 | |
| 11 | 2016 | 68 | |
| 12 | 2014 | 47 | |
| 13 | 2017 | 37 | |
| 14 | 2020 | 37 | |
| 15 | 2011 | 34 | |
| 16 | 2007 | 33 | |
| 17 | 2021 | 31 | |
| 18 | 2018 | 30 | |
| 19 | 2015 | 25 | |
| 20 | 2022 | 25 |
About James Hakim
James Hakim is a scholar working on Infectious Diseases, Emergency Medicine, Virology, Pharmacy and Microbiology, having authored 37 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (5 papers), HIV-related health complications and treatments (4 papers), Infectious Diseases and Tuberculosis (3 papers), Tuberculosis Research and Epidemiology (3 papers), HIV Research and Treatment (2 papers), Antifungal resistance and susceptibility (1 paper) and Clinical Laboratory Practices and Quality Control (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (129 citations), Emergency Medicine (141 citations), Epidemiology (212 citations) and Nephrology (65 citations). James Hakim has collaborated with scholars based in Zimbabwe, United Kingdom and Uganda. Frequent co-authors include Cissy M Kityo, Innocent T. Gangaidzo, Jens Mielke, Robert S. Heyderman, Peter R. Mason, Valerie J. Robertson, Andrew Ddungu Kambugu, Paula Munderi, Charles F. Gilks and Diana M. Gibb. Their work appears in journals such as New England Journal of Medicine, The Lancet HIV, Clinical Infectious Diseases, BMC Infectious Diseases and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.